Screener
CorMedix CRMD Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $257.68M+61.6% | $179.08M+170% | $145.83M+258% | $49.48M+39.8% | $159.41M+457% | ||
| $0-100% | $0-100% | $3.69M-66.5% | $7.22M-32.8% | $31.4M+84.0% | ||
| $161.31M+276% | $154.81M+183% | $171.23M+231% | $158.57M+812% | $42.91M+20,697% | ||
| $38.58M+300% | $30.73M+310% | $29.72M+291% | $28.92M+335% | $9.63M+140% | ||
| $480.55M+93.7% | $383.11M+164% | $367.05M+220% | $259.54M+255% | $248.06M+366% | ||
| $7.85M+378% | $6.17M+257% | $5.96M+226% | $4.35M+129% | $1.64M-14.3% | ||
| $30M— | $30M— | $30M— | $17.52M— | —— | ||
| $358.47M+20,499% | $368.77M+20,476% | $379.07M+20,455% | $254.61M+13,328% | $1.74M— | ||
| $904.05M+258% | $815.64M+445% | $826.14M+595% | $750.86M+868% | $252.6M+338% | ||
| $10.24M+76.1% | $12.83M+564% | $7.88M+358% | $20.45M+1,422% | $5.82M+73.9% | ||
| $187.4M+491% | $128.78M+274% | $174.27M+415% | $133.64M+623% | $31.71M+185% | ||
| $443.22M+1,286% | $378.59M+991% | $420.84M+1,131% | $376.73M+1,896% | $31.97M+177% | ||
| 160M0.0% | 160M0.0% | 160M0.0% | 160M0.0% | 160M0.0% | ||
| -$111.99M+62.6% | -$137.97M+56.7% | -$176.58M+48.0% | -$190.6M+46.0% | -$299.16M+14.6% | ||
| $460.83M+109% | $437.05M+280% | $405.31M+379% | $374.13M+537% | $220.63M+378% | ||
| $904.05M+258% | $815.64M+445% | $826.14M+595% | $750.86M+868% | $252.6M+338% |
FAQ
- What are CorMedix's total assets?
- CorMedix (CRMD) holds $904.1M in total assets, up 257.9% year over year.
- How much cash does CorMedix have?
- CorMedix holds $257.7M in cash and equivalents.
- Can CorMedix cover its short-term obligations?
- Its current ratio is 2.56 — current assets exceed current liabilities.
- Where does CorMedix's balance sheet data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
